B. Ahrén

Diabetes · 2000–2004

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.

Whom B. Ahrén trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Kahn

Who trusts B. Ahrén overall

  1. S. Seino
  2. P. Havel
  3. B. Wajchenberg

Papers from B. Ahrén's perspective

Ordered by how strongly the researchers B. Ahrén trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion (Circulation)
  2. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes (Diabetologia)
  3. Diabetes and endothelial dysfunction: a clinical perspective. (Endocrine reviews)
  4. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. (The Lancet)
  5. Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 (Nature)
  6. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes (Nature)
  7. Quantitative estimation of insulin sensitivity.
  8. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. (Diabetes)
  9. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. (New England Journal of Medicine)
  10. Dementia and Alzheimer disease incidence: a prospective cohort study. (Archives of Neurology)

Their papers